Atrial Arrhythmia |

Atrial Arrhythmia research study

What is the primary objective of this study?

The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.

Who is eligible to participate?

Inclusion Criteria: - Patient implanted (primo-implant, replacement, upgrade) with dual chamber pacemaker from less than two months or implanted at inclusion. Exclusion Criteria: - Contraindicated for cardiac pacing, according to the ESC and ACC/AHA/HRS guidelines - Permanent or persistent atrial tachyarrhythmia

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Atrial Arrhythmia

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status


Start Date: March 2010

Completed Date: August 31, 2017


Type: Observational


Primary Outcome: Atrial arrhythmias incidence

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: LivaNova


More information:

Discuss Arrhythmia